The findings have led to the first
primary vaccine study that we are conducting as a multi-center international trial.
Not exact matches
Kang's
primary research focuses on designing and developing effective
vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to
study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.
[5] The
primary outcome of the
study was safety and tolerability, with immunological response to the
vaccine as a secondary outcome.
Guided by the Behavioral
Vaccine Theory of prevention, this
study uses a no - control group design to examine intervention variables that predict favorable changes in depressive symptoms at the six - to - eight week follow - up in at - risk adolescents who participated in a
primary care, Internet - based prevention program.